Cabinet Approves Capital Infusion for the three Public Sector General
Insurance Companies – Oriental Insurance Company Limited, National Insurance Company
Limited and United India Insurance Company Limited
[Press Release/08.07.2020]
The Union Cabinet chaired by the Prime Minister,
Narendra Modi has approved the capital infusion for an overall value of Rs.12,450
crore; (including Rs. 2,500 crore infused in FY 2019-20)
in the three Public Sector General Insurance Companies (PSGICs) namely Oriental
Insurance Company Limited (OlCL), National Insurance Company
Limited (NICL) and United India Insurance Company Limited (UIICL) but of which Rs.3,475
crore will be released immediately; while the balance Rs,6475 crore will be infused
later. Cabinet also approved increase in authorised share
capital of NICL to Rs.7,500 crore and that of UIICL and
OlCL to Rs 5,000 crore respectively
to give effect to the capital infusion. Further, the process of merger has been
ceased so far in view of the current scenario and instead, the focus shall be on
their profitable growth.
The capital infusion of Rs.3,475 Crore will be allocated to three PSGICs viz. OlCL, NICL and UIICL as the first tranche in the current financial
year and the. balance amount will be released in one or
more tranches. To give effect to the infusion, the authorised
capital of NICL will be increased to Rs. 7,500 Crore and
that of UIICL and OlCL to Rs.5,000
Crore respectively.
Impact
The capital infusion will enable the three PSGICs
to improve their financial and solvency position, meet the insurance needs of the
economy, absorb changes and enhance the capacity to raise resources and improved
risk management.
Financial implications:
In the current financial year, the immediate
financial implication would be Rs.3,475 crore as a result
of capital infusion in three PSGICs namely OlCL, NICL
and UIICL as the first tranche which will be followed by Rs.
6,475 Crore.
Way forward:
To ensure optimum utilization of the capital
being provided, the Government has issued guidelines in the form of KPIs aimed at
bringing business efficiency and profitable growth. In the meanwhile, given the
current scenario, the process of merger has been ceased so far and/instead focus
shall be on their solvency and profitable growth, post capital infusion.